Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Wix.com (WIX) PT Raised to $140 at Cantor Fitzgerald: Can Benefit in Agentic Era
-
Alphabet's (GOOGL) Ads in Gemini Compelling New Revenue Stream - Cantor Fitzgerald
-
Oracle (ORCL) PT Lowered to $320 at Cantor Fitzgerald: Well-positioned in AI Race
-
Corvus Pharmaceuticals' (CRVS) Demonstrates Improvements in EASI - Cantor Fitzgerald
-
Bluerock Acquisition prices $150 million IPO at $10 per unit
-
Bluerock Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
Form DEFA14A CANTOR FITZGERALD INFRAS
-
Almonty Industries closes $129.4 million share offering
-
Almonty Industries Inc. Announces Closing of Upsized US$129,375,000 Underwritten Offering of Common Shares in the United States Including Full Exercise of Over-Allotment Option
-
SwapGlobal Reuses $20B Fund’s Collateral to Execute Derivatives Trade
-
SenderraRx Announces Strategic Growth Investment from Nautic Partners
-
Kingswood U.S. Expands Investment Banking Capabilities and Deepens Existing Alliance with ArcStone Securities, LLC with Equity Stake and Enhanced 2026 Strategy
-
AIR acquires German hookah brand NameLess to expand global reach
-
AIR Strengthens Global Footprint with Acquisition of Leading German Hookah Brand NameLess
-
Fulcrum Therapeutics prices $175 million public offering at $13.50 per share
-
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants
-
CVS Health (CVS) Still Steady Operator With Strong Management - Cantor Fitzgerald
-
Lexeo Therapeutics' (LXEO) PKP2-ACM Program Under the Radar - Cantor Fitzgerald
-
Redwire (RDW) PT Lowered to $9 at Cantor Fitzgerald: 'Still Offers Healthy Upside'
-
Braze (BRZE) Platform is Critical for Brands Today - Cantor Fitzgerald
-
AeroVironment (AVAV) PT Lowered to $315 at Cantor Fitzgerald
-
Meshflow Acquisition Corp. prices $300 million IPO at $10 per unit
-
Meshflow Acquisition Corp. Announces Pricing of $300 Million Initial Public Offering
-
Vera Therapeutics prices $261 million stock offering at $42.50 per share
-
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
-
Orchid Island Capital Announces December 2025 Monthly Dividend and November 30, 2025 RMBS Portfolio Characteristics
-
Form N-CSRS CANTOR FITZGERALD INFRAS For: Sep 30
-
Almonty prices upsized $112.5 million share offering at $6.25 per share
-
Almonty Industries Inc. Announces Pricing of Upsized US$112,500,000 Underwritten Offering of Common Shares in the United States
-
Twenty One to Begin Trading on NYSE Under Ticker “XXI” With Over 43,500 Bitcoin in Holdings After Successful Completion of Business Combination
-
Fulcrum Therapeutics launches $150 million stock offering
-
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock
-
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
-
Splitero, Funds Managed by Blue Owl, and Antarctica Capital Close $283.3 Million Home Equity Investment Inaugural Securitization
-
Cross River Achieves Milestone with $288 Million Commercial Mortgage-Backed Securities Transaction
-
Mirum Pharmaceuticals to acquire Bluejay Therapeutics for $620 million
-
Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
-
Progyny (PGNY) PT Raised to $31 at Cantor Fitzgerald: Differentiated Strategy Prime
-
Humana (HUM) May Have Limited Near-term Upside - Cantor Fitzgerald
-
Tenet Healthcare (THC) Can Underperform, In-Line Guidance Bold - Cantor Fitzgerald
-
CIGNA (CI) Recovery Highly Likely in 2027 - Cantor Fitzgerald
-
Acadia Healthcare's (ACHC) Lowered Guidance Thrice - Cantor Fitzgerald
-
Vertical Aerospace's (EVTL) Leadership Increased Holdings ~50% - Cantor Fitzgerald
-
Archer's (ACHR) Karem Partnership Will Aid Aircraft Development - Cantor Fitzgerald
-
Eve Holding's (EVEX) Aircraft can Benefit from BETA Aftermarket - Cantor Fitzgerald
-
Form 8-K Cantor Fitzgerald Income For: Dec 05
-
Sabra (SBRA) is at Lesser Risk Versus Smaller Rung REITs - Cantor Fitzgerald
-
CommVault Systems (CVLT) Seeing No Change to Outlook - Cantor Fitzgerald
-
salesforce (CRM) is Formalizing, Maturing Pricing Strategy - Cantor Fitzgerald
-
salesforce's (CRM) Story Shows AI Isn't Displacing Core Software - Cantor Fitzgerald

